About this WG
Ten years have passed since iPSC were first made. During that time, as iPSC technology became widespread, various studies have been conducted. And now, development of innovative medicines and regenerative medicine using iPSC is extremely expected.
In this WG, point to consider for matters related to the development and evaluation of pharmaceuticals using iPSC is discussed.
Established
August, 2018
Members
Office of New Drug I-V
Office of Cellular and Tissue-based Products
Office of Vaccines and Blood Products
Office of Research Promotion
Publication
Maruyama Y, Tsunoda S, Saijo Y, Nosaka Y, Okudaira S, Kameda T,Hayashi Y, Izumi K, Maki K, Shinagawa K,
Application of InducedPluripotent Stem Cells in Drug Discovery and Regenerative Medicine.
Regul Sci Med Prod. 10(1):33-40, 2020